Skip to main content
Sirnaomics Ltd. logo

Sirnaomics Ltd. — Investor Relations & Filings

Ticker · 2257 LEI · 2549004JEEDTBC6EHW37 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 402 across all filing types
Latest filing 2025-08-28 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing HKEX 2257

About Sirnaomics Ltd.

http://www.sirnaomics.com

Sirnaomics Ltd. is a clinical-stage RNA therapeutics biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs. The company's pipeline addresses a broad spectrum of therapeutic areas, including oncology, fibrosis-related diseases, skin conditions, antiviral and cardiometabolic diseases, and medical aesthetics. Sirnaomics utilizes proprietary delivery platforms, which form the foundation of its RNA-based therapeutics. These platforms include the Polypeptide Nanoparticle (PNP) system for administering mRNA vaccines and therapeutics, and the GalNAc delivery platform for systemic administration of liver-targeting RNA interference (RNAi) therapeutics. The company is recognized as the first to achieve positive Phase IIb clinical outcomes in oncology using clinical-stage RNA therapeutics.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025' and contains the full text of the interim report, including financial statements (Statement of Profit or Loss, Statement of Financial Position, etc.), management discussion and analysis, and corporate information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2025
2025-08-28 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 1% confidence The document is a Hong Kong Exchange announcement titled “NOTICE OF BOARD MEETING” informing shareholders of the date the Board will meet to approve interim results. It is neither the interim report itself nor a dividend, nor a management change, nor any of the other specific categories. It is a general regulatory announcement. Hence it falls under the fallback category “Regulatory Filings” (RNS).
2025-08-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly return (Form FF301) filed with the Hong Kong Exchange under Chapter 19B listing rules, detailing movements in authorised/registered share capital, issued shares, treasury shares, share options, and RSU schemes. It is not an AGM presentation, earnings release, annual or interim report, nor does it announce publication of another report. It is a routine regulatory submission that does not fit any more specific category and therefore falls under General Regulatory Filings.
2025-08-05 English
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 1% confidence The document is an announcement from Sirnaomics Ltd. regarding the resignation of an independent non-executive director and the resulting board changes. This clearly falls under Board/Management Information as it details changes in the company's board of directors and senior management.
2025-07-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Share Issue/Capital Change Classification · 1% confidence The document is a formal HKEX FF301 Monthly Return under Chapter 19B of the Exchange Listing Rules, detailing movements in authorised/registered share capital, issued shares, treasury shares, share options and other share issuance arrangements for the month ended 30 June 2025. It is not an earnings release, annual or interim report, nor a Q&A transcript, but a regulatory submission about share capital changes. This aligns with the “Share Issue/Capital Change” category (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2025-07-04 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 1% confidence The document is a formal listing of the company’s board of directors, their roles, and committee memberships. It details the board structure and governance framework rather than announcing a specific transaction, voting result, or share issue. This fits the definition of a Governance Information (CGR) filing, which covers board composition and governance practices.
2025-07-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.